Moderna aims to roll out a combined COVID-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an annual shot. The single vaccine for COVID-19, influenza andrespiratory syncytial virus—a common virus that causes the ...
Covid-19 booster vaccine jabs for millions of people in England will begin to be offered this week, the NHS has announced. The vaccine will be available to care home residents, people who are 75 and over, and the immunosuppressed aged 12 and over. ...
BEIJING, May 19 (Xinhua) -- A study by Chinese researchers has found that the COVID-19 booster vaccination can markedly reduce the immune escape of the Omicron variant, underscoring the necessity for the eligible population to get a third booster jab to combat the pandemic. The researchers fro...
Johnson & Johnson's COVID-19 vaccine has been a minor player in the US vaccination drive so far, but the company hopes it can have a bigger role as a booster shot. The drugmaker has filed for approval of a second dose of its one-shot Ad26.COV2.S vaccine
Over-50s could be given a booster of the COVID-19 jab in the autumn to protect those most vulnerable from the virus.
Scientists at the University of Nottingham have confirmed that an autumn 'booster' dose of a COVID-19 vaccine will be an effective way to protect people from existing, and potentially future, variants of concern.
The article reports on the announcement by United Kingdom's (UK) Department of Health and Social Care (DHSC) that a COVID-19 booster vaccine and flu jabs will be offered to adult people over 50 years old in the autumn of 2022.Practice Nursing...
The company is already running studies of NVX-CoV2373 as a booster shot, giving a third dose to people who received the shot in its phase 2 programme, and has said it generated antibody levels that were four- to six-times higher than were found to be protective in its other trials. Whi...
"Between November, December and January over 38,000 people were admitted to hospital with the virus.” The groups of people eligible for a booster jab this autumn are: Adults aged 65 years and over Residents in a care home for older adults ...
The Pharmaceutical Services Negotiating Committee (PSNC) has said it is in "urgent talks" with the NHS following news of the government's drive to provide a COVID-19 booster jab to all eligible adults in England by the end of December 20... C Wickware - 《Pharmaceutical Journal》 被引量...